SMTL ID : 2aid.1

STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 4 residues within 4Å: Chain A: G.49, I.50 Chain B: I.50 Ligands: THK.2 Ligand excluded by PLIP CL.3: 3 residues within 4Å: Chain B: G.48 Ligands: THK.2, THK.4 Ligand excluded by PLIP

2 x THK: 4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL(Non-covalent)

THK.2: 18 residues within 4Å: Chain A: L.23, D.25, G.27, A.28, D.29, D.30, G.48, P.81, V.82 Chain B: L.23, D.25, G.27, A.28, G.49, V.82 Ligands: CL.1, CL.3, THK.4 6 PLIP interactions: 3 interactions with chain A, 3 interactions with chain B Hydrophobic interactions: A:L.23, A:P.81, B:L.23 Salt bridges: A:D.25, B:D.25 Hydrogen bonds: B:D.25 THK.4: 15 residues within 4Å: Chain A: R.8, L.10, L.23, I.50, P.81, V.82 Chain B: A.28, D.29, D.30, V.32, I.47, G.48, I.84 Ligands: THK.2, CL.3 10 PLIP interactions: 7 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:A.28, B:V.32, B:I.47, A:V.82, A:V.82 Hydrogen bonds: B:D.29, B:D.29, B:D.30 Salt bridges: B:D.29 pi-Cation interactions: A:R.8

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rutenber, E. et al., Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. J.Biol.Chem. (1993)

Release Date

1997-10-15

Peptides

HUMAN IMMUNODEFICIENCY VIRUS PROTEASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HUMAN IMMUNODEFICIENCY VIRUS PROTEASE

Related Entries With Identical Sequence